310 related articles for article (PubMed ID: 31971362)
1. Nanovector Assembled from Natural Egg Yolk Lipids for Tumor-Targeted Delivery of Therapeutics.
Tang Z; Luo C; Jun Y; Yao M; Zhang M; He K; Jin L; Ma J; Chen S; Sun S; Tao M; Ding L; Sun X; Chen X; Zhang L; Gao Y; Wang QL
ACS Appl Mater Interfaces; 2020 Feb; 12(7):7984-7994. PubMed ID: 31971362
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Antitumor Efficacy of Macrophage-Mediated Egg Yolk Lipid-Derived Delivery System Against Breast Cancer.
Lv Y; Jun Y; Tang Z; Li X; Tao M; Zhang Z; Liu L; Sun S; Wang Q; Luo C; Zhang L
Int J Nanomedicine; 2020; 15():10075-10084. PubMed ID: 33335395
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte-Mediated Combined Targeted Chemo and Gene Therapy for Esophageal Cancer.
Jun Y; Tang Z; Luo C; Jiang B; Li X; Tao M; Gu H; Liu L; Zhang Z; Sun S; Han K; Yu X; Song X; Tao G; Chen X; Zhang L; Gao Y; Wang QL
ACS Appl Mater Interfaces; 2020 Oct; 12(42):47330-47341. PubMed ID: 32997489
[TBL] [Abstract][Full Text] [Related]
4. Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib.
Duan W; Liu Y
Drug Des Devel Ther; 2018; 12():2149-2161. PubMed ID: 30034219
[TBL] [Abstract][Full Text] [Related]
5. α- Tocopherol succinate loaded nano-structed lipid carriers improves antitumor activity of doxorubicin in breast cancer models in vivo.
Fernandes RS; Silva JO; Seabra HA; Oliveira MS; Carregal VM; Vilela JMC; Andrade MS; Townsend DM; Colletti PM; Leite EA; Cardoso VN; Ferreira LAM; Rubello D; Barros ALB
Biomed Pharmacother; 2018 Jul; 103():1348-1354. PubMed ID: 29864917
[TBL] [Abstract][Full Text] [Related]
6. Combination prostate cancer therapy: Prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone.
Sun G; Sun K; Sun J
Drug Deliv; 2021 Dec; 28(1):1132-1140. PubMed ID: 34121558
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
8. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
9. Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy.
Zhang M; Xiao B; Wang H; Han MK; Zhang Z; Viennois E; Xu C; Merlin D
Mol Ther; 2016 Oct; 24(10):1783-1796. PubMed ID: 27491931
[TBL] [Abstract][Full Text] [Related]
10. In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice.
Ding Z; Wang D; Shi W; Yang X; Duan S; Mo F; Hou X; Liu A; Lu X
Int J Nanomedicine; 2020; 15():8383-8400. PubMed ID: 33149582
[TBL] [Abstract][Full Text] [Related]
11. 1, 2-Dihexadecanoyl-sn-glycero-3-phosphoethanolamin (DPPE), doxorubicin and folic acid conjugated micelles for cancer management in tumor bearing BALB/c mice.
Uttekar PS; Yadav VD; Bhagwat DA
Bioorg Med Chem Lett; 2021 Oct; 50():128337. PubMed ID: 34438013
[TBL] [Abstract][Full Text] [Related]
12. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
Sun B; Deng C; Meng F; Zhang J; Zhong Z
Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
[TBL] [Abstract][Full Text] [Related]
13. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo.
Zheng G; Zheng M; Yang B; Fu H; Li Y
Biomed Pharmacother; 2019 Aug; 116():109006. PubMed ID: 31152925
[TBL] [Abstract][Full Text] [Related]
14. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug.
Jain A; Agarwal A; Majumder S; Lariya N; Khaya A; Agrawal H; Majumdar S; Agrawal GP
J Control Release; 2010 Dec; 148(3):359-67. PubMed ID: 20854859
[TBL] [Abstract][Full Text] [Related]
15. In vivo dual-targeted chemotherapy of drug resistant cancer by rationally designed nanocarrier.
Wang Y; Zhao R; Wang S; Liu Z; Tang R
Biomaterials; 2016 Jan; 75():71-81. PubMed ID: 26491996
[TBL] [Abstract][Full Text] [Related]
16. Real-time imaging tracking of a dual-fluorescent drug delivery system based on doxorubicin-loaded globin- polyethylenimine nanoparticles for visible tumor therapy.
Zhang Y; Wei C; Lv F; Liu T
Colloids Surf B Biointerfaces; 2018 Oct; 170():163-171. PubMed ID: 29906701
[TBL] [Abstract][Full Text] [Related]
17. Modified methods of nanoparticles synthesis in pH-sensitive nano-carriers production for doxorubicin delivery on MCF-7 breast cancer cell line.
Hamidu A; Mokrish A; Mansor R; Razak ISA; Danmaigoro A; Jaji AZ; Bakar ZA
Int J Nanomedicine; 2019; 14():3615-3627. PubMed ID: 31190815
[No Abstract] [Full Text] [Related]
18. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Shi L; Tang C; Yin C
Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
20. Albumin-Albumin/Lactosylated Core-Shell Nanoparticles: Therapy to Treat Hepatocellular Carcinoma for Controlled Delivery of Doxorubicin.
Teran-Saavedra NG; Sarabia-Sainz JA; Velázquez-Contreras EF; Ramos-Clamont Montfort G; Pedroza-Montero M; Vazquez-Moreno L
Molecules; 2020 Nov; 25(22):. PubMed ID: 33233564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]